MD, Medical Roboticist,
Clinical Systems Engineering,
Chilean in Cambridge, UK
____
R&D PG experience at the 🇺🇸 (CMU/Pitt) & Postgraduate training (M.Res & PhD candidate) Imperial College London 🇬🇧
Opinions=own
HYBRID MD-ENGINEER
I’m a clinician by background, with an essential experience in surgery, anaesthesiology, and critical care. Since I got my M.D. degree, I have been working side by side with biomedical engineers (all flavours: mechanic mechatronic, biomaterials, computing, and clinical systems) in the USA and the U.K.
At the same time, I keep my clinical skills up-to-date. I’m a registered doctor in Chile and in the U.K. My last time treating patients was in September 2019. Also designed the national strategy for preclinical and clinical validation of Emergency Mechanical Ventilators for Chile’s Ministry of Science.
I’m happily working at TTP (a unique R&D consulting company located in Cambridge, UK). There, I work as a clinical systems engineer. My role is to find all stakeholders’ needs in healthcare, envision and develop high-tech solutions that solve surgery and medicine’s needs in general.
I’ll be happy to talk with anyone with problems (I prefer to call them needs) in their daily clinical practice; if you have ideas for new medical technologies; or if you are in a company and want to explore collaborations.
I love the Chilean Andes (practicing mountaineering since Uni, with summits over 5000m), climbing (indoors, basic experience outdoor), cycling (MTB), and playing classic guitar.
I love science, technology, and how their integration into clinical practice improves our patients’ quality of life. Anything MedTech!
www.favilar.org
http://linkedin.com/in/favi1ar
Invited by: Kasia Zdanowicz
if the data has not been changed, no new rows will appear.
Day | Followers | Gain | % Gain |
---|---|---|---|
October 26, 2023 | 128 | +2 | +1.6% |
October 28, 2022 | 126 | +2 | +1.7% |
May 05, 2022 | 124 | +1 | +0.9% |
December 22, 2021 | 123 | +1 | +0.9% |
October 06, 2021 | 122 | +3 | +2.6% |
August 24, 2021 | 119 | +8 | +7.3% |